Rothwell Figg is a law firm specializing in intellectual property and technology law. The firm publishes blogs and articles focusing on topics such as patent litigation, regulatory developments, and legal strategies related to pharmaceuticals, biotechnology, and emerging technologies like artificial intelligence. Their content often covers updates on patent office procedures, legislative proposals affecting patent law, biosimilar drug development, and intellectual property licensing. Rothwell Figg provides analysis relevant to patent practitioners, innovators, and companies involved in technology and life sciences sectors, emphasizing practical implications of legal and regulatory changes.